These results suggest that high CCT3 expression is associated with leukemia and the JAK-STAT3 signaling pathway, and that CCT3 expression may promote multiple myeloma progression by regulating MYC mainly through the JAK-STAT3 signaling pathway. This evidence concerns the gene CCT3 and plasma cell myeloma.